{Reference Type}: Letter
{Title}: Recurrence and malignant risk of ameloblastoma: A demographic study of 1626 cases from east China.
{Author}: Liu W;Zheng C;Zhang X;Hu H;
{Journal}: Oral Oncol
{Volume}: 148
{Issue}: 0
{Year}: 2024 Jan 6
{Factor}: 5.972
{DOI}: 10.1016/j.oraloncology.2023.106651
{Abstract}: <B>BACKGROUND: </B>Ameloblastoma is characterized by aggressive nature, high recurrence rate, occasional malignant transformation, but recurrence and malignant incidence of ameloblastoma are not yet addressed by a large-scale case series study.<BR><B>METHODS: </B>This study provided a detailed description of the relationship between demographic characteristics and recurrence and malignant cases with different clinical types of ameloblastoma (n = 1626).<BR><B>RESULTS: </B>The overall incidence of recurrence and malignancy was 17.2 % and 3.4 %, respectively. Notably, we observed that there were multiple recurrent episodes (mean time, 24.3-28.7 months) among ameloblastoma patients. Multivariate analysis revealed that age of > 45 years (odds ratios (OR), 2.10; 95 % confidence interval (CI), 1.17-3.76), male (OR, 3.24; 95 %CI, 1.49-6.99), maxilla (OR, 5.58; 95 %CI, 3.11-10.0), and pre-existing recurrence (OR, 3.79; 95 %CI, 2.05-7.01) as independent factors were associated significantly with increased risk of malignancy.<BR><B>CONCLUSIONS: </B>Identification of the clinical factors responsible for increased risk of malignancy provides better insight in management planning for ameloblastoma.